文献速递肝病

代谢与遗传因素是酒精性肝纤维化严重程度的最强预测因子

Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-12-04

这项活检对照的横断面研究纳入325例过量饮酒者,评估代谢指标和四个基因多态性对酒精性肝病严重程度的预测价值。结果显示,胰岛素抵抗(HOMA-IR≥2.5)是肝纤维化分期和肝脏炎症的最强独立预测因子,PNPLA3和TM6SF2风险变异进一步加重风险。

要点

  • HOMA-IR≥2.5独立预测更高肝纤维化分期(OR=3.04)。
  • PNPLA3 rs738409-G和TM6SF2 rs58542926-T与更高纤维化分期相关。
  • LDL<2.60 mmol/L、年龄>50岁也独立预测更高纤维化分期。

核心结论

  • 胰岛素抵抗是酒精性肝病患者肝纤维化分期和肝脏炎症的最强预测因子,遗传易感性进一步加重风险。

研究设计与样本

  • 活检对照的横断面研究,纳入325例有过度饮酒史的患者,检测代谢指标并分析四个单核苷酸多态性。

主要发现

  • 25%的患者有严重纤维化或肝硬化,59%的患者HOMA-IR≥2.5。
  • HOMA-IR随纤维化分期增加而升高,LDL和总胆固醇则相应降低。
  • 携带PNPLA3 rs738409-G或TM6SF2 rs58542926-T风险变异的个体纤维化分期更高。

关键数值与推荐

  • 多变量回归中,HOMA-IR≥2.5(OR=3.04,95%CI 1.90-4.87)、LDL<2.60 mmol/L(OR=2.05,95%CI 1.33-3.16)、TM6SF2 rs58542926-T(OR=1.99,95%CI 1.17-3.37)、年龄>50岁(OR=1.66,95%CI 1.03-2.70)和PNPLA3 rs738409-G(OR=1.54,95%CI 1.11-2.12)独立预测更高纤维化分期。
  • 肝脏炎症活动的独立预测因子为HOMA-IR、活跃饮酒、年龄和PNPLA3风险变异。
  • 脂肪变性的预测因子为活跃饮酒、甘油三酯升高和PNPLA3风险变异。

临床怎么用

  • 对过度饮酒者应详细评估代谢指标(尤其是胰岛素抵抗)和基因多态性,以识别肝纤维化高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Individual risk for developing alcohol-related liver disease (ALD) varies greatly. We hypothesized that metabolic risk factors and genetic polymorphisms predict severity of ALD. METHODS: Biopsy-controlled, cross-sectional study in patients with a history of excessive drinking. We measured the homeostatic model assessment of insulin resistance (HOMA-IR), plasma triglycerides, high- and low-density lipoproteins (HDL, LDL), and total cholesterol. Moreover, we genotyped four single nucleotide polymorphisms in PNPLA3 (rs738409C>G), TM6SF2 (rs58542926C>T), MBOAT7 (rs641738C>T), and HSD17B13 (rs72613567T>TA). We assessed predictors of higher fibrosis stage using multivariable ordered logistic regression. RESULTS: Of 325 included patients, 25% had severe fibrosis or cirrhosis and 59% had HOMA-IR ≥2.5. HOMA-IR increased for each fibrosis stage, while there was a similar decrease in LDL and total cholesterol. Individuals with risk variant PNPLA3 rs738409-G or TM6SF2 rs58542926-T had higher fibrosis stage. In multivariable regression, HOMA-IR ≥2.5 (OR = 3.04, 95% CI 1.90-4.87), LDL <2.60 mmol/L (OR = 2.05, 95% CI 1.33-3.16), TM6SF2 rs58542926-T (OR = 1.99, 95% CI 1.17-3.37), age above 50 years (OR = 1.66, 95% CI 1.03-2.70), and PNPLA3 rs738409-G (OR = 1.54, 95% CI 1.11-2.12) independently predicted higher fibrosis stage. Independent predictors of hepatic inflammatory activity were HOMA-IR, active drinking, age, and PNPLA3 risk variant. Active drinking, elevated triglycerides, and PNPLA3 risk variant predicted steatosis. CONCLUSIONS: Insulin resistance is the strongest predictor of liver fibrosis stage and hepatic inflammation in patients with alcohol-related liver disease. Genetic susceptibility further aggravates this risk. These data highlight the clinical value of detailed metabolic and genetic profiling of patients with excessive alcohol use.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Israelsen M, Juel HB, Detlefsen S, et al. Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis. Clin Gastroenterol Hepatol. 2020. PMID: 33279778. doi:10.1016/j.cgh.2020.11.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。